Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins

Area of Science:

• Hepatology
• Virology
• Cell Biology

Background:

• Hepatitis C virus (HCV) and very low-density lipoproteins (VLDLs) are uniquely secreted by hepatocytes.
• HCV replication is restricted to the liver, but the underlying mechanisms are not fully understood.

Purpose of the Study:

• To investigate the cellular mechanisms of HCV replication and secretion.
• To explore the relationship between HCV and VLDL assembly pathways in hepatocytes.

Main Methods:

• Isolation of membrane vesicles containing the HCV replication complex from human hepatoma cells.
• Analysis of protein enrichment in these vesicles, focusing on VLDL assembly factors like apolipoprotein B (apoB), apoE, and microsomal triglyceride transfer protein (MTTP).
• Assessment of HCV production in hepatoma cells treated with MTTP inhibitors or apoB-directed siRNA.

Main Results:

• HCV-replication-containing vesicles are enriched with key VLDL assembly proteins (apoB, apoE, MTTP).
• Inhibition of MTTP or silencing of apoB significantly reduced infectious HCV production in hepatoma cells.
• These findings indicate a dependency of HCV replication on the host cell's VLDL assembly machinery.

Conclusions:

• HCV utilizes host VLDL assembly pathways and proteins for its replication and/or secretion.
• The liver-specific nature of HCV production may be linked to the hepatocyte-specific VLDL assembly process.
• Targeting VLDL assembly proteins presents a potential therapeutic strategy for treating HCV infection.